Scientific Programme
386
Wednesday
Thursday
friday
Saturday
S-145
Symposium
10.15– 11.45 h
|
Hall 3
D
U
E
Topic 19:
Health services research and
health care policy
Psychiatry without compulsory treat-
ment? Experience and findings
› Section: Psychosocial Care Reseach
Chairs: Ingo Schäfer, Hamburg (Germany)
Tilman Steinert, Ravensburg
(Germany)
001
The public’s attitude to compulsory
treatment in psychiatry – 1993 and 2011
Georg Schomerus, Stralsund (Germany)
Herbert Matschinger, Matthias Angermeyer
002
15 months of inpatient psychiatry
without compulsory drug treatment –
observations and findings
Martin Zinkler, Heidenheim (Germany)
003
Psychiatry without compulsory
treatment: quantitative and qualitative
data
Tilman Steinert, Ravensburg (Germany)
Erich Flammer, Susanne Jaeger, Franziska
Hüther
004
Psychiatry without compulsory
treatment: experiences from the Nether-
lands
Eric Noorthoorn, Maastricht (The
Netherlands)
S-154
Symposium
10.15– 11.45 h
|
Hall 8
Topic 19:
Health services research and
health care policy
Right to medical treatment and right to
autonomy
Chairs: Norman Sartorius, Geneva
(Switzerland)
Wolfgang Gaebel, Düsseldorf
(Germany)
001
The United Nations Convention on
the Rights of Persons with Disabilities
(CRPD) and Mental Health Law
Peter Bartlett, Nottingham (United
Kingdom)
002
Parity of esteem between physical
and mental health
Sue Bailey, London (United Kingdom)
003
Right to medical treatment and
right to autonomy from clinical perspec-
tive in psychiatry
Levent Küey, Istanbul (Turkey)
S-161
Symposium
10.15– 11.45 h
|
Salon 11/12
Topic 1:
Organic mental disorders,
dementia, F0
Preclinical diagnosis of neuropsychiat-
ric disorders, an essential requirement
for the target selection and design of
preventive trials
› In cooperation with DGBP – Deutsche Ge-
sellschaft für Biologische Psychiatrie e.V.
Chairs: Stefan Teipel, Rostock (Germany)
Bartosz Zurowski, Lübeck (Germany)
001
Machine learning approaches to
detect preclinical signs of neurodegener-
ation from multimodal imaging data
Stefan Klöppel, Freiburg im Breisgau
(Germany)
002
Novel diagnostic biomarkers and
intervention targets for preclinical neu-
rodegeneration
Anja Schneider, Göttingen (Germany)
003
Early detection of psychoses – what
can neuroimaging contribute?
Anita Riecher-Rössler, Basel (Switzerland)
Stefan Borgwardt, Nikolaos Koutsouleris
004
Exploring adolescents‘ vulnerability
for reward-related disorders: the IMA-
GEN study
Sophia Schneider, Hamburg (Germany)
Uli Bromberg, Christian Büchel
